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ABSTRACT 
 
Model of study: Validation study.  
Objective: To evaluate the psychometric performance of the Brazilian version of the Insulin 
Management Diabetes Self-Efficacy Scale - IMDSES.  
Methodology: Reliability (internal consistency - Cronbach’s α), convergent and criterion validity were 
assessed. Data were gathered from 127 patients with type 2 diabetes mellitus (T2DM) in use of insulin 
through the application of sociodemographic and clinical instruments and the Brazilian versions of the 
Summary of Diabetes Self-Care Activities Measures - SDSCA and the IMDSES.  
Results: It was observed “ceiling effect” in Insulin domain. Reliability was confirmed in all IMDSES 
domains and Total Score (α=0.87). The convergent construct validity was supported by significant 
negative moderate to weak magnitude correlations between the scores of IMDSES domains and the 
scores of SDSCA domains. Criterion validity was partially supported by the weak magnitude correlation 
between the General Managements domain and the Total Score of IMDSES and serum levels of glycated 
hemoglobin (r=0.22; p=0.02).  
Conclusion: The Brazilian version of IMDSES presented satisfactory psychometric measures and may 
be useful to evaluate the effectiveness of nursing interventions aimed at optimizing the self-efficacy of 
the T2DM patient in the management of his treatment. 
 
Keywords: Type 2 Diabetes Mellitus. Self Efficacy. Validation Studies. Nursing. Questionnaires.  
Psychometric Properties.  
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RESUMO 
 
Modelo de estudo: estudo de validação.  
Objetivo: Avaliar o desempenho psicométrico da versão brasileira “Escala de Auto-eficácia no manejo 
da insulina” - IMDSES. 
Metodologia: A confiabilidade (consistência interna - α Cronbach), a validade convergente e a validade 
de critério foram avaliadas. Os dados foram coletados de 127 pacientes com diabetes mellitus tipo 2 
(DM2) em uso de insulina por meio da aplicação de instrumentos sociodemográficos e clínicos e as 
versões brasileiras “Summary of Diabetes Self-Care Activities Measures” - SDSCA and the IMDSES. 
 
Resultados: Observou-se “efeito de teto” no domínio da insulina. A confiabilidade foi confirmada em 
todos os domínios do IMDSES obtendo pontuação total satisfatória (α=0,87). A validade con-vergente 
de constructo foi confirmada por correlações negativas significativas de magnitude mo-derada a fraca 
entre os escores dos domínios do IMDSES e os escores de domínio da SDSCA. A validade de critério foi 
parcialmente confimada por correlação de magnitude fraca entre o domí-nio de Gerenciamento Geral e 
o escore total do IMDSES e níveis de hemoglobina glicada (r=0.22; p=0.02). 
 
Conclusão: A versão brasileira do IMDSES apresentou medidas psicométricas satisfatórias e pode ser 
útil para avaliar a efetividade das intervenções de enfermagem que visam otimizar a autoeficácia do 
paciente com DM2 no manejo do tratamento. 
 
Palavras-chave: Diabetes Mellitus Tipo 2. Autoeficácia. Estudos de Validação. Enfermagem.  
Questionários. Propriedades Psicométricas.  
 
 
 
1. INTRODUCTION 
 
As a chronic condition, Type 2 Diabetes 
mellitus (T2DM) requires the individual to adopt 
complex practices to control its progression and  
prevent its complications.1 One of the strategies used 
to adopt healthy practices is to improve pa-tient 
confidence in their capacity/ability to perform the 
behavior, that is, the improvement of their self-
efficacy (SE).2 SE, a central construct of Social Cog-
nitive Theory, can be defined as the individual´s 
perception of their ability to organize and perform 
certain actions to achieve a target outcome.2  
A high SE is needed in order to obtain a per-
sonal wellness effect aimed at adopting positive 
behaviors, considering that the higher the indi-
vidual conviction of the ability to produce desired 
results, the more intense and lasting will be the 
attempt to deal with the challenges inherent  
behavioral changes.3 The relationship between SE 
and adoption of health behaviors has been inves-
tigated in numerous studies which suggest that 
the strengthening of SE relates to the adoption of  
health practices  in different  clinical  conditions4,5 and 
among those with Diabetes mellitus (DM).6- 10 
Regarding T2DM, SE has been considered an 
important outcome measure of self-manage-ment 
 
interventions.11 In this sense, studies of pa- 
 
1 2 2 
 
 
 
tients with T2DM demonstrated that greater SE 
predicted better nutrition and medication manage-
ment, more frequent self-monitoring of blood glu-
cose and enhanced physical activity. While higher 
levels of SE have been considered indicator of 
better diabetes control, lower levels have been  
seen as an indicator of worse diabetes control.12 
Aimed at evaluating the relationship be-  
tween SE and the best performance by people with 
T2DM in adopting healthy behaviors, differ-ent 
instruments that measure how capable the 
individual perceives himself to play their care plan 
were created.13,14,15 Among them, the Insulin 
Man-agement Diabetes Self-efficacy Scale  
(IMDSES),16 developed in the United States to 
measure SE of adults with diabetes (type 1 and 2) 
specific for those treated with insulin. Thus, the 
aim of this study was to expand the evaluation of 
the psy-chometric properties of the Brazilian 
version of IMDSES through its use in patients with 
type 2 diabetes mellitus. 
 
2. METHOD 
 
2.1 Study design and Setting 
 
This methodological study was conducted in 
a Primary care Unit and in a specialized outpa- 
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tient clinic of DM of a city university hospital in the 
Campinas, state of São Paulo, Brazil. Data col-
lection was carried out between May and Octo-ber 
of 2012.  
All procedures performed in studies involv-
ing human participants were in accordance with 
the ethical standards of the institutional and/or 
national research committee and with the 1964 
Helsinki declaration; as well as its later amend-
ments or comparable ethical standards. The study 
was approved by the local research ethics com-
mittee (No.1180/2011). 
 
2.2 Sample selection and data collection 
 
All patients (age > 18 years) with T2DM in-
sulin applicants were included in outpatient moni-
toring. The exclusion criteria were: patients us-ing 
insulin for at least one year, who had chronic 
complications in the advanced stage as those with 
chronic renal failure diagnosis on hemodialysis, 
blindness, heart failure class III and IV and/or 
motor sequel of stroke were excluded. 
 
The interviews were carried out individually 
by means of a patient approach in a private set-
ting and consultation with available data in the 
registries. The sociodemographic and clinical data 
were obtained and Brazilian versions of the Sum-
mary of Diabetes Self-Care Activities Measures 
were applied - SDSCA and IMDSES 28 through 
interviews. This alteration of data gathering tech-
nique has been performed elsewhere with no 
harms to participants or the instrument psycho-
metric performance.17
 
 
To estimate the sample size, data from a 
pilot study among 20 subjects were used. Then 
sample size was calculated based on the Pearson 
correlation coefficient, considering as the null hy-
pothesis, correlation coefficient = 0 (zero), α = 
0.05 and β = 88%. The correlation coefficients 
were considered among the IMDSES Total Score 
and the domains of Specific Food and Glucose 
Moni-toring Summary of SDSCA, estimating the 
sample size of 127 subjects. 
 
2.3 Measurement 
 
Insulin Management Diabetes Self-Effi-
cacy Scale (IMDSES): the original American ver-
sion consists of 28 items that measure self-effi- 
 
 
 
cacy for seven behaviors: General Management, 
Diet, Exercise, Feet care, blood glucose monitor-
ing, insulin administration and Prevention, Detec-
tion and Treatment of Hypoglycemia/Hyperglyc-
emia. The answers are rated on a Likert-type scale 
of six points with the possibility of a “not apply”  
answer.16,18 The cultural adaptation of IMDSES 
28-items for the Brazilian context 17 was 
conducted in subjects with type 1 diabetes 
mellitus, dependent on insulin, and it has been 
modified from the original scale. The Likert-type 
response scale of six points has been changed to 
four-point and maintained the possibility of a fifth 
alternative “do not apply”. Thus, the Brazil-ian 
version of IMDSES consists of 20 items dis-
tributed in the domains - General Management, 
Diet and Insulin. In this study we chose to use the 
Brazilian version of IDMSES with 28 items, without 
excluding the eight items proposed by Gastal, 
Pinheiro, and Vazquez.17 The calculation of the 
total score corresponds to the average of the 
scores, with a possible variation of 28 up to  
112. The higher the score, the lower the self-effi-
cacy. Item 13 (drafted in the negative) needs re-
verse scoring for calculating the total score. 
 
Summary of Diabetes Self-Care Activities 
Measures (SDSCA): the scale built to assess the 
level of self-care in patients with T2DM, in the last 
seven days, consists of 11 items by measuring six 
domains: General Diet, Specific Diet, Physical 
Activity, Blood Glucose Monitoring, Feet Care and 
Tobacco. Also, additional items were included re-lated 
to self-care recommendations (expanded version) 
 
that are not accounted for score calcu-lating.
19
 The 
adaptation of expanded SDSCA into the Brazilian 
context was also conducted in pa-tients with T2DM.20 
It was chosen in the Brazilian version by the inclusion 
of items in the expanded version, as an item of Feet 
Care, items on Medi-cation and Tobacco. Thus, the 
Brazilian version of SDCSA consists of 15 self-care 
assessment items in six domains: General Diet, 
Specific Diet, Physi-cal Activity, Glucose Monitoring, 
Feet Care and medication; plus three additional items 
for Tobacco assessment. The score is obtained for 
each dimen-sion by the average number of days 
(scale 0-7), zero being the least desirable and seven 
to the more favorable situation. 
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2.4 Data Analysis 
 
The statistical software program SAS (“Sta-
tistical Analysis System”) version 9.2 was used for 
the following analyses: 
 
• Descriptive analysis of sociodemographic and 
clinical variables and the scores of the domains 
and the total score of the Brazilian version of 
the IMDSES and SDSCA; 
 
• Ceiling and floor effects: floor effect of IMDSES 
28-item was evaluated by the percentage of 
patients who scored the 10% worse possible 
results of the scale). Ceiling effect was evalu-
ated by the percentage of patients who rated 
the 10% best possible results of the scale;21  
• Practicability: assessed by time spent in the 
in-strument application;  
• Acceptability: evaluated by the percentage 
of patients who responded all items;  
• Reliability regarding internal consistency: esti-
mated using Cronbach’s alpha coefficient. Sat-
isfactory internal consistency α > 0.70 was con-
sidered;22  
• Convergent Construct Validity: assessed through 
the use of the Spearman correlation coefficient 
to test the scores of the Brazilian version of the 
IMDSES and of the SDSCA. In order to test con-
vergent validity, moderate to strong magnitude 
correlations were hypothesized between simi-lar 
constructs of IMDSES and SDCDA domains and 
no correlation or weak magnitude correla-tions 
were hypothesized between dissimilar con-
structs; 
 
• Predictive Criterion Validity: assessed by the 
Spearman correlation coefficient to test the cor-
relation between the IMDSES and the value of 
serum glycated hemoglobin (HbA1c) - one of the 
indicators considered “gold standard” in glycemic 
control. To test the validity criterion, moderate to 
strong magnitude negative correlations were 
hypothesized between IMDSES Total score and 
serum levels of glycated hemoglobin. 
 
For the interpretation of the magnitude of 
the correlation coefficients, the criteria adopted by  
Fishbein and Ajzen23 was used, which considers 
correlations ≤ 0.30 of low magnitude, from 0.31 up 
to 0.50 of moderate magnitude and > 0.5 of 
strong magnitude. A significance level of 5% was 
adopted. 
 
 
 
3. RESULTS 
 
It was found a predominance of women 
(59.8%) with a mean age of 58.3 (SD = 9.3) 
years old, with an average schooling of 6.1 (SD = 
4.6) years. The average length of diagnosis of DM 
was of 15.1 (SD = 9.3) years and the mean 
duration of treatment with insulin was 7.7 (SD = 
6.6) years. Among the associated clinical 
conditions, hyper-tension (85.2%), metabolic 
syndrome (83.5%), obesity (80%) and 
dyslipidemia (71.8%) were highlighted. The mean 
of the HbA1c was 9.0% (SD = 2.1). 
 
3.1 Analysis of the practicability, acceptability, 
ceiling and floor effects and descriptive 
measures of the Brazilian version of the 
 
IMDSES 
 
Practicability 
 
As for the practicability of IMDSES, there 
was an average application time of 21.7 (SD = 
10.4) minutes. 
 
Acceptability 
 
Regarding acceptability, all patients re-
sponded to all of the items. 
 
Ceiling and floor effects 
 
In the analysis of ceiling and floor effects, 
assessing the proportion of 10% of the best and 
worst possible score of the scale, there was no 
floor effect for domains and Total Score. A ceiling 
effect was observed in the Insulin domain of the 
IMDSES, that is, 18.9% of participants scored in 
the best possible scale score in this domain. 
 
Descriptive analysis 
 
It has been found for the three domains of 
the Brazilian version of IMDSES as well as for the 
Total Score; scores above the possible averages, 
which indicates the self-efficacy level of commit-
ment of the interviewees. The General Manage-
ment domain had less involvement of self-efficacy 
level with an average of 2.3 (SD = 0.3) while the 
Insulin domain had the greater average commit-
ment of 3.0 (SD = 0.5). The analysis of data on 
SDSCA shows score below the average expected 
for all domains, especially for Specific diet (3.7), 
showing a low level of self-care (see Table 1). 
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Table 1  
Descriptive analysis of domains and total score of the Brazilian version of the Insulin Management Diabetes Self-
Efficacy Scale - IMDSES 28-items and the Summary of Diabetes Self-Care Activities Measures - SDSCA (n = 127). 
 
 
      Floor Ceiling 
 Number Average  Variation Effect Effect 
IMDSES domains of items (SD*) Median observed (%) (%) 
        
Diet 08 2.5 (0.3) 2.5 1.7-3.5 0.0 0.0 
Insulin 05 3.0 (0.5) 3.0 2.0-4.0 0.0 18.9 
General Management 15 2.3 (0.3) 2.3 1.4-2.5 0.0 0.0 
IMDSES – Total 28 2.5 (0.3) 2.5 1.8-2.7 0.0 0.0 
SDSCA domains        
General diet 02 4.1 (2.4) 4.0 0.0-7.0 13.4 27.5 
Specific diet 03 3.7 (1.4) 3.7 0.0-6.7 1.6 5.5 
Physical activity 02 1.1 (2.1) 0.0 0.0-7.0 74.8 8.7 
Glucose monitoring 02 4.7 (2.6) 6.0 0.0-7.0 12.6 47.2 
Feet care 03 4.5 (2.7) 4.7 0.0-7.0 19.0 42.0 
Medication 03 6.8 (0.9) 7.0 2.3-7.0 0.0 92.1  
 
*Standard deviation 
 
 
 
3.2 Reliability Analysis 
 
The reliability regarding internal consist-
ency of the IMDSES was measured through 
Cronbach’s alpha coefficient (α) estimation. Con-
sidering satisfactory internal consistency as α >  
0.70 Cronbach’s alpha22 was satisfactory for all 
the IMDSES domains and for the Total Score. The 
analysis of item-total correlation and Cronbach’s 
alpha if the item is deleted showed that in the Diet 
domain, coefficient lift to the exclusion of items 1 
and 10. In the General Management domain, it 
was found higher coefficients with the exclusion of 
items 12, Item 13 and 27 (see Table 2). 
 
 
3.3 Convergent Construct Validity 
 
The convergent construct validity was as-
sessed by the correlation between the Total score 
and domains of the Brazilian version of IMDSES 
and the scores obtained by the application of 
SDSCA. Data evidences that the Diet domain of 
IMDSES showed a negative correlation of moder- 
 
 
 
 
ate magnitude with the General Diet domain (r=-
0.40; p<0.0001) and low magnitude of correla-
tion with the Specific Diet domains (r=-0.27 
p<0.0001), Feet Care (r=-0.29; p<0.0001) and 
medication (r=-0.26; p<0.0001) of SDSCA. The 
domain General Management of IMDSES also 
showed moderate correlation with the Feet Care 
domain (r=-0.33; p<0.0001) and low magnitude 
of correlation with the domain General Diet, Spe-
cific Diet and Physical Activity of the SDSCA. It 
appears that the Insulin domain of IMDSES pre-
sented a single weak correlation magnitude with 
the Feet Care domain of SDSCA (r=-0.24; 
p<0.0001). The other correlations were consid-
ered significant although with tiny practical value. 
 
In turn, the total score of IMDSES correlated 
with moderate magnitude with the Feet Care do-
main (r=-0.39; p<0.0001) and significant correla-
tions of weak magnitude with other domains of 
SDSCA, except to the domains Blood Glucose 
Moni-toring and Medication, for which correlations 
were observed with the Total Score of IMDSES 
(see Table 3). 
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Table 2  
Correlation item-total, Cronbach’s alpha coefficients, and Cronbach’s alpha if the item is deleted from the  
Brazilian version of Insulin Management Diabetes Self-Efficacy Scale - IMDSES 28-items (n = 127).  
 
          Cronbach´s 
          Alpha 
        Item-total Cronbach´s (if the item 
 IMDSES  Scale correlation Alpha is deleted) 
           
 Diet   0.71   
 Item 1  I can carry out most of the time, treatment of diabetes -0.001 0.732  
       in my everyday life. For example, applying insulin,    
       do the diet.    
 Item 5   Can I dine at the same time every day? 0.095  0.702 
 Item 6  I can keep my diet when I eat out in known locations 0.356  0.639 
       (for example, Friends)?    
 Item 7  Can I keep my diet when I make meals away from 0.356  0.640 
       home, in unfamiliar places?    
 Item 8  Am I sure, I will be able to keep my diet when people 0.596  0.699 
       around me do not know that I am diabetic?    
 Item 9   Am I sure, I can keep my diet every day? 0.452  0.673 
 Item 10  Can I correctly replace one type of food for another 0.269  0.732 
       from the same group? For example: Changing rice    
       for potatoes (or other food of the same group)    
 Item 11   Can I keep my diet when I go to parties? 0.369  0.681 
        
 Insulin   0.94   
 Item 22  I can adjust me a dose of insulin based on the results 0.278  0.944 
       of sugar in blood or urine tests, when necessary    
 Item 23  I am sure I can adjust my insulin dose, when changes 0.464  0.934 
       in my daily routine (some change that I am used to    
       doing every day)?    
 Item 24  Do I know how to adjust my insulin dose to avoid 0.492  0.935 
       sugar crash when practicing physical exercise?    
 Item 25  I know what kind of adjustment in insulin dose should 0.260  0.933 
       perform when my blood sugar is higher than it should?    
 Item 26   Can I adjust my insulin dose when I have a cold or flu? 0.297  0.936 
      
 General Management  0.76  
 Item 2   Am I confident in my ability to deal with diabetes? 0.547  0.741 
 Item 3  Do I feel secure in using my knowledge about diabetes, 0.571  0.741 
       including daily treatment?    
 Item 4   Do I believe I can follow the diabetes routines every day? 0.571  0.741 
 Item 12   Can I not perform the regular physical activity? 0.067  0.791 
 Item 13  I cannot do physical exercise, except when I am -0.361  0.815 
       in the mood.    
 Item 14  Do I know when I should call (search) to my doctor 0.763  0.744 
       because of problems with my feet?    
 Item 15  Can I apply the recommended daily lotion on my feet? 0.464  0.740 
 Item 16  Can I test my blood sugar or urine when I am away 0.525  0.736 
       from home?    
 Item 17   Can I recognize when my blood sugar is too high? 0.543  0.741 
 Item 18   Can I recognize when my blood sugar is too low? 0.364  0.764 
 Item 19  Do I do blood or urine sugar testing more often than 0.429  0.766 
       usual when I’m sick?    
 Item 20   Can I apply insulin using the correct technique? 0.754  0.750 
 Item 21  Do I have ease of applying insulin when I am away 0.664  0.728 
       from home?    
 Item 27  Am I sure, that the treatment of diabetes does not -0.127  0.792 
       hurt my daily routine?    
 Item 28  Do I believe I am able to follow the planned treatment 0.831  0.740 
       of diabetes, even when changes in my daily routine    
       (some change what I am used to doing every day)?    
       
 IMDSES  Total  0.87  
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Table 3  
Spearman’s correlation coefficients between the domains and total score of the Brazilian version of the Insulin 
Management Diabetes Self-Efficacy Scale - IMDSES and domains of the Summary of Diabetes Self-Care Activities 
Measures - SDSCA (n = 127). 
 
 
    SDSCA – domains   
        
  General Specific Physical Glucose Feet  
IMDSES domains Diet Diet Activity monitoring Care Medication 
        
  r* (p**) r(p) r(p) r(p) r(p) r(p) 
Diet 
-0.40 -0.27 -0.10 -0.18 -0.29 -0.26 
<0.0001 (<0.0001) (0.26) (0.03) (<0.0001) (<0.0001)   
Insulin 
0.05 0.05 -0.18 -0.07 -0.24 0.02 
(0.52) (0.51) (0.03) (0.41) (<0.0001) (0.77)   
General -0.26 -0.22 0.24 -0.17 -0.33 -0.07 
management (<0.0001) (0.01) (<0.0001) (0.04) (<0.0001) (0.43) 
Total IMDSES 
- 0.29 -0.22 -0.23 -0.21 -0.39 -0.17 
(<0.0001) (0.01) (<0.0001) (0.01) (<0.0001) (0.05)   
         
*r = Spearman correlation coefficients;** p = p-value. 
 
 
 
3.4 Criterion Validity 
 
Criterion validity was tested by correlational 
evidence between scores of the domains and the 
Total score of IMDSES and serum levels of HbA1c. 
Weak positive magnitude correlations were found 
between the score of the General Management 
domain (r=0.22; p=0.02) and the Total score 
(r=0.22; p=0.02) of IMDSES and the average 
value of HbA1c. 
 
4. DISCUSSION 
 
The aim of this study was to deepen the 
assessment of the psychometric properties of the 
Brazilian version of IMDSES through its use in 
patients with T2DM. Regarding the analysis of the 
practicability of IMDSES, it is important to note that 
the original scale was constructed to be self-
administered and in this study, considering the low 
socioeconomic status and poor education of the study 
group (mean of 6.1 years of education), it was 
chosen for its application through inter-views. Thus, 
the evaluation of the practicability of IMDSES showed 
a moderate time length for application in interview 
format (21.7 minutes). Previous study24 conducted 
with 181 patients with 
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DM, in which 54% had up to 12 years of study, 
the short-form IMDSES was easily filled, implying 
a low cost to the respondent, although it has not 
been described the average time of application. In 
other studies using the instrument, the practi-
cability has not been evaluated.  
As for acceptability, the results show good 
acceptance of the instrument since all the patients 
responded to all of the items. However, a high 
percentage of responses “Does not apply/not 
applied was recorded to items 14 and 15, which 
belongs to the domain of General Management of 
the Brazilian version of the IMDSES. This find-ing 
may indicate the need for greater investment in 
the education of T2DM patients regarding their 
treatment, since 47.7% of patients enrolled had a 
diagnosis of peripheral neuropathy. 
 
It has been found a ceiling effect on insulin 
domain, i.e., 18.9% of participants scored the best 
possible results of the scale in this domain. The  
same finding was observed previously24 for the 
domains of Physical activity and Routine variables, 
which are encompassed in the domain of General 
Management in the Brazilian version of IMDSES.  
As for reliability, this study demonstrated 
satisfactory internal consistency for all the do-
mains and to the Total Score of IMDSES, support- 
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ing the original findings of the study that also used 
the IMDSES of 28 items, finding satisfactory 
Cronbach’s alpha for the Total Score (α=0.82) and 
for most of its domains. Previous studies using 
modified versions of IMDSES balanced by the 
number of items also showed satisfactory inter-nal 
consistency for all the domains and the Total 
Score.17,18,25 In our study, analysis of item-total 
correlation and Cronbach’s alpha if the item de-
leted showed little meaning for the value of 
Cronbach’s alpha of Diet domain with 0.71 to 0.73 
to the exclusion of items 1 and 10. It was also 
noted slight increase of α in the General Manage-
ment domain with 0.76 excluding items of 12 and 
27 and most importantly increased Cronbach’s 
alpha of 0.78 to 0.81 if deleted item 13. In the  
study of Rapley, Passmore, and Phillips,24 they 
have also shown that the items 12 and 13 (both 
related to exercise) had a lower value of 
Cronbach’s alpha. In the study of Gastal, Pinheiro, 
and Vazquez,17 items 12 and 13 were also ex-
cluded, however, because of their low factor 
loadings (<0.30) in the factor analysis.  
Like previous history studies,16,18 the cor-
relations between the constructs of self-efficacy 
and self-care by applying the respective scales 
were of weak to moderate magnitude, confirming 
the construct validity of the Brazilian version of 
IMDSES. Although the humble findings given the 
size of correlations, it is relevant to highlight the 
capacity of this instrument to correctly measure 
such a complex construct as self-efficacy; which 
can be much more defying among a low literacy 
sample such as ours – this evidence can not be 
mistreated, since this sample probably represents 
most of Brazilian population. This relationship 
supports the underlying assumption that confi-
dence of the individual in their abilities to perform 
a given behavior determines what behavior it can 
engage and how intense and lasting will be the 
engagement to deal with the challenges to achiev-
ing the expected results. 
 
Criterion validity was assessed by correla-
tion with HbA1c, which reflects the average blood 
glucose control in the three months prior to its 
acquisition, was supported in this study by weak 
magnitude of correlations between the domain 
General Management and Total Score of the Bra-
zilian version of IMDSES and HbA1c. Gastal, 
 
 
 
Pinheiro, and Vazquez17 found a significant asso-
ciation between self-efficacy level in Insulin do-
main of the Brazilian version of IMDSES 20 items 
and the level of HbA1c (ANOVA) and a linear trend 
that the higher self-efficacy, the lower level of 
HbA1c. In the study by Hurley & Harvey
16
 found 
an association between all domains of original 
IMDSES and the level of HbA1c. Despite the small 
correlations, it is noticeable that the questionnaire 
was able to demonstrate correlations with such a 
strong variable such as HbA1c, since relations with 
objective measures are considered as the most 
strong relations an instrument may demon-strate. 
We must highlight that HbA1c is one of the best 
choices to assess self-efficacy behavior for insulin 
use, since it is the best serum variable to evaluate 
glucose levels – which reflect patient’s adherence 
to T2DM as a whole – including medi-cation (as 
insulin), diet and physical activity. HbA1c has been 
used in guidelines worldwide as an ex-cellent 
marker to adherence. 
 
In the literature, there is no consensus on 
the magnitude of the relationship between the 
level of self-efficacy and HbA1c. In a recent study, 
HbA1c levels were significantly correlated with the 
degree of self-efficacy among type 1 diabetics, but 
not among individuals with type 2 diabetes, sug-
gesting that the factors that contribute to self-
efficacy in diabetes patients with type 1 and type 2 
are probably different.26
 
 
As for the limitations, we must recognize 
that the alteration in the way the instrument was 
delivered (self-applied to interview) may modify 
the way participants respond to the questionnaire  
– although this alteration is supported else-  
where.17 Besides, limitations regarding the use of 
self-reported measures must be taken into ac-
count, as bias of social desirability (in which the 
respondent answers what he believes the inter-
viewer expects to hear) and memory.  
In summary, the results of this study point 
to the reliability and partially support convergent 
construct and criterion validity of the Brazilian 
version of IMDSES when applied to T2DM patients. 
It is expected that the findings of this research 
contribute to the psychometric refinement of the 
Brazilian version of IMDSES 28-items with a view 
to their future use in assessing the impact of nurs-
ing interventions on patient´s care diabetic insu- 
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lin applicant types 1 and 2. It is recommended to 
carry out further studies with sample expanded to 
assess the validity of known groups (such as good 
glucose control x poor glucose control, us-ing 
HbA1c) and the responsiveness of the Brazil-ian 
version of the IMDSES 28-items in T2DM. It is also 
suggested the replication of this study among 
subjects from different socioeconomic status to 
confirm its practicability and acceptability. 
 
5. CONCLUSION 
 
The results of this study indicate that the 
Brazilian 28-item IMDSES requires a moderate 
time of application and have good acceptability 
when applied to T2DM patients with low literacy. It 
seems that the instrument has a potential to 
measure worsens and improves in self-efficacy, 
since no relevant ceiling or floor effects were 
found. The findings point to satisfactory reliability 
regarding internal consistency and convergent 
construct validity. Predictive criterion validity 
tested by the relationship with serum levels of 
HbA1c was partially supported. The availability of 
a reliable and valid instrument is an essential tool 
for evaluating the effectiveness of nursing inter-
ventions aimed at optimizing self-efficacy of T2DM 
outpatients in the management of their treatment. 
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